Upper Lower Extremities Articles & Analysis: Older
27 news found
The rapidly growing Australian orthopaedics devices company, Field Orthopaedics (FO) has just completed a fresh round of fundraising, equipping it with $5million in new capital for a push into the US$11billion trauma and extremities market. As one of the fastest growing market sub-sectors, at a rate of 7-10% per annum, hand and wrist orthopaedics is now around 40% of the ...
OSSIO, Inc., an orthopedic fixation technology company, today announced that it has received a contract with Vizient, Inc., making the company’s portfolio of bio-integrative OSSIOfiber products available at negotiated pricing to health care providers in Vizient’s group purchasing organization (GPO) under a three-year contract starting March 1. OSSIO’s contract with Vizient ...
Food and Drug Administration (FDA) for maintenance of alignment and fixation of bone fractures, comminuted fractures, fragments, osteotomies, arthrodesis and bone grafts of the upper extremity, fibula, knee, ankle and foot in the presence of appropriate brace and/or immobilization. ...
Medartis is a top player in musculoskeletal extremity healthcare and specifically in orthopaedic hand surgery. By combining its global reach and commercial expertise with Field Orthopaedics’ innovative solutions for hand extremity trauma, we can rapidly extend our sales and distribution footprint, and ultimately reach more patients in more countries. ...
RevBio, Inc., announced that it has been awarded a Phase II Small Business Innovation Research (SBIR) grant expected to total $2 million over two years from the National Institute on Aging, part of the National Institutes of Health. This funding will allow the company to pursue the treatment of wrist fractures with its patented bone adhesive technology known as Tetranite®. Because the bone ...
The addition of ExsoMed, whose products support an intramedullary approach to treating hand fractures, enhances Acumed’s comprehensive portfolio of upper extremity solutions for simple to complex injuries. “Demand for minimally invasive surgical devices continues to grow and the ExsoMed products are great additions to our minimally invasive ...
Bluegrass Vascular Technologies, a private medical technology company focused on innovating lifesaving devices and methods for vascular access procedures, announced today the publication of a paper featured on the cover of the June 2022 issue of the Journal of Vascular Surgery (JVS) which reports on the use the Surfacer System to perform an Inside-Out® procedure to obtain central venous ...
NAPLES, Fla. - Catalyst OrthoScience, a medical device company focused on the upper extremity orthopedics market, is pleased to announce that Dr. Todd Wilson has joined Catalyst as Vice President of Medical Education and Training effective immediately. “We are excited to have an executive with Todd’s experience join our team at Catalyst OrthoScience,” said Catalyst ...
Naples, FL, April 12, 2022 - Catalyst OrthoScience, a medical device company focused on the upper extremity orthopedics market, is pleased to announce that David Sharp has joined Catalyst as Vice President of Global Marketing effective immediately. “We are excited to have an executive with David’s experience join our team at Catalyst OrthoScience,” said Catalyst OrthoScience ...
Synergy Biomedical, LLC, a developer of innovative biomaterial products, today announced the launching of BIOSPHERE® FLEX SP EXTREMITIES, Synthetic Bioactive Bone Graft. Using Synergy’s proprietary BIOSPHERE® Technology, BIOSPHERE® FLEX SP Extremities is a sheet putty composed of innovative spherical bioactive glass granules combined with a ...
Visit booth #2408 for product demonstrations of the Archer™ Shoulder Systems NAPLES, Fla., March 22, 2022 – Catalyst OrthoScience Inc. (Catalyst), a medical device company focused on the upper extremity orthopedics market, will be at the American Academy of Orthopedic Surgeons (AAOS) 2022 Annual Meeting, March 23-25, 2022, in Chicago. At booth #2408, Catalyst will have demos and the ...
Catalyst OrthoScience initiates a controlled, limited user release of the planning software to test the software in clinical settings NAPLES, Fla., March 21, 2022 – Catalyst OrthoScience Inc. (Catalyst), a medical device company focused on the upper extremity orthopedics market, today announced that the platform technology for its Archer™ 3D Targeting planning software received ...
With the update 2.0 of the virtual reality therapy system CUREO® of the med-tech company CUREosity from Düsseldorf, therapy is optimized with intuitive, digital and efficient tools. Based on user analysis and evaluation of feedback from clinics, therapists and patients, we have further developed our system to relieve therapists. The update has been officially available since January 31. ...
Previous studies of TFR procedures using ultrasound guidance have shown they can be performed in procedure rooms or office settings utilizing local anesthesia and have been associated with reduced pain and rapid recovery.1-3 Most patients are able to return to work and normal activities faster than those who undergo traditional TFR surgery.3 “The launch of UltraGuideTFR reflects our ...
Spinologics Inc. and Importek have announced today the launch of Cervision™, an upper-extremity patient positioning device for cervical spine surgery, in Brazil. This launch marks the first international sales development of this product since its domestic introduction. “We are pleased to introduce Cervision™ in the Brazilian market”, says Dustin Arless, Director of ...
Experience our innovative virtual reality (VR) therapy system CUREO live at the MEDICA, November 15-18, 2021. We will be at the NRW booth in hall 3, booth number C80. We will also give presentations and talk about the advantages that come with virtual reality-based therapy Come by and check out live demonstrations of our smart therapy system that supports cognitive and sensorimotor ...
Checkpoint Surgical announces the full commercial release of the Checkpoint Guardian Nerve Stimulator, the next generation of its classic intraoperative nerve stimulation technology. The new Checkpoint Guardian optimizes intraoperative nerve assessment capability, particularly for nerve repair procedures, providing more precise controls and information to take nerve assessment to the next level. ...
IpsiHand robotic hand-piece uniquely leverages brain-computer interface technology for chronic stroke rehabilitation IpsiHand also has been granted U.S. FDA Breakthrough Device Designation Neurolutions, Inc., a medical device company developing and commercializing a first-of-its-kind device leveraging brain-computer interface (BCI) technology for upper extremity chronic stroke rehabilitation, ...
Today, the U.S. Food and Drug Administration authorized marketing of a new device indicated for use in patients 18 and older undergoing stroke rehabilitation to facilitate muscle re-education and for maintaining or increasing range of motion. The Neurolutions IpsiHand Upper Extremity Rehabilitation System (IpsiHand System) is a Brain-Computer-Interface (BCI) device that assists in rehabilitation ...
MicroTransponder Inc., today announced that the pivotal clinical trial results for the Company's investigational Vivistim® Paired Vagus Nerve Stimulation (VNS) System have been published in The Lancet. Each year in the US, 50-60% of the 658,000 stroke survivors have upper extremity motor deficits that persist for many months to years after their stroke. The Lancet reports that patients ...